Cargando…
Alkylaminophenol Induces G1/S Phase Cell Cycle Arrest in Glioblastoma Cells Through p53 and Cyclin-Dependent Kinase Signaling Pathway
Glioblastoma (GBM) is the most common type of malignant brain tumor in adults. We show here that small molecule 2-[(3,4-dihydroquinolin-1(2H)-yl)(p-tolyl)methyl]phenol (THTMP), a potential anticancer agent, increases the human glioblastoma cell death. Its mechanism of action and the interaction of s...
Autores principales: | Doan, Phuong, Musa, Aliyu, Candeias, Nuno R., Emmert-Streib, Frank, Yli-Harja, Olli, Kandhavelu, Meenakshisundaram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454069/ https://www.ncbi.nlm.nih.gov/pubmed/31001122 http://dx.doi.org/10.3389/fphar.2019.00330 |
Ejemplares similares
-
Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol through the Modulation of EGFR and CSC Signaling Pathways
por: Doan, Phuong, et al.
Publicado: (2020) -
Alkylaminophenol and GPR17 Agonist for Glioblastoma Therapy: A Combinational Approach for Enhanced Cell Death Activity
por: Doan, Phuong, et al.
Publicado: (2021) -
Synthesis and Preclinical
Validation of Novel Indole
Derivatives as a GPR17 Agonist for Glioblastoma Treatment
por: Nguyen, Phung, et al.
Publicado: (2021) -
Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation)
por: Viswanathan, Anisha, et al.
Publicado: (2019) -
Erratum: Viswanathan, A., et al. Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect (Running Title: Cancer Cells Death Signalling Activation). Cells 2019, 8, 1624
por: Viswanathan, Anisha, et al.
Publicado: (2020)